Indicators for early prediction of outcome in sepsis;Parameter der frühen prädiktion des sepsisverlaufs

Chirurg

Volumn 76, Issue 9, 2005, Pages 837-844

  Novotny, A ^a   Emmanuel, K ^a   Bartels, H ^a   Siewert, J R ^a   Holzmann, B ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cytokines; Indicators; Prognosis; Risk assessment; Sepsis

Indexed keywords

CALCITONIN; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 8; L SELECTIN; PROCALCITONIN; PROTEIN PRECURSOR;

BLOOD; HUMAN; MORTALITY; POSTOPERATIVE COMPLICATION; PREDICTION AND FORECASTING; PROGNOSIS; REVIEW; RISK FACTOR; SEPTIC SHOCK; SURGICAL INFECTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

CALCITONIN; HOSPITAL MORTALITY; HUMANS; INTERLEUKIN-12; INTERLEUKIN-18; INTERLEUKIN-8; L-SELECTIN; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN PRECURSORS; RISK FACTORS; SHOCK, SEPTIC; SURGICAL WOUND INFECTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 24944480283     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-005-1077-z     Document Type: Review

References (58)

1. Fang XM, Schroder S, Hoeft A, Stuber F (1999) Comparison of two polymorphisms of the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis. Crit Care Med 27:1330-1334
2. Hensler T, Heidecke CD, Hecker H et al. (1998) Increased susceptibility to postoperative sepsis in patients with impaired monocyte IL-12 production. J Immunol 161:2655-2659
3. Kahlke V, Schafmayer C, Schniewind B, Seegert D, Schreiber S, Schroder J (2004) Are postoperative complications genetically determined by TNF-beta Ncol gene polymorphism? Surgery 135:365-373
4. Majetschak M, Flohe S, Obertacke U et al. (1999) Relation of a TNF gene polymorphism to severe sepsis in trauma patients. Ann Surg 230:207-214
5. Mira JP, Cariou A, Grall F et al. (1999) Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 282:561-568
6. Riese J, Woerner K, Zimmermann P, Denzel C, Hohenberger W, Haupt W (2003) Association of a TNF-beta gene polymorphism with complications after major abdominal operations. Shock 19:1-4
7. Stuber F, Petersen M, Bokelmann F, Schade U (1996) A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit Care Med 24:381-384
8. Weighardt H, Heidecke CD, Westerholt A et al. (2002) Impaired monocyte IL-12 production before surgery as a predictive factor for the lethal outcome of postoperative sepsis. Ann Surg 235:560-567
9. Faist E (1996) The mechanisms of host defense dysfunction following shock and trauma. In: Rietschel ET, Wagner H (Hrsg) Pathology of septic shock. Springer, Berlin Heidelberg New York, S 259-274
10. Guillou PJ (1993) Biological variation in the development of sepsis after surgery or trauma. Lancet 342:217-220
11. Hensler T, Hecker H, Heeg K et al. (1997) Distinct mechanisms of immunosuppression as a consequence of major surgery. Infect Immun 65:2283-2291
12. Windsor AC, Klava A, Somers SS, Guillou PJ, Reynolds JV (1995) Manipulation of local and systemic host defence in the prevention of perioperative sepsis. Br J Surg 82:1460-1467
13. Brune IB, Wilke W, Hensler T, Holzmann B, Siewert JR (1999) Downregulation of T helper type 1 immune response and altered pro-inflammatory and anti-inflammatory T cell cytokine balance following conventional but not laparoscopic surgery. Am J Surg 177:55-60
14. Carlei F, Schietroma M, Cianca G, Risetti A, Mattucci S, Ngome Enang G, Simi M (1999) Effects of laparoscopic and conventional (open) cholecystectomy on human leukocyte antigen-DR expression in peripheral blood monocytes: correlations with immunologic status. World J Surg 23:18-22
15. Decker D, Schondorf M, Bidlingmaier F, Hirner A, von Ruecker AA (1996) Surgical stress induces a shift in the type-1/type-2 T-helper cell balance, suggesting down-regulation of cell-mediated and up-regulation of antibody-mediated immunity commensurate to the trauma. Surgery 119:316-325
16. Akira S (2000) The role of IL-18 in innate immunity. Curr Opin Immunol 12:59-63
17. Hershman MJ, Cheadle WG, Wellhausen SR, Davidson PF, Polk HC Jr (1990) Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg 77:204-207
18. Wakefield CH, Carey PD, Foulds S, Monson JR, Guillou PJ (1993) Changes in major histocompatibility complex class II expression in monocytes and T cells of patients developing infection after surgery. Br J Surg 80:205-209
19. Watanabe E, Hirasawa H, Oda S, Matsuda K, Hatano M, Tokuhisa T (2005) Extremely high interleukin-6 blood levels and outcome in the critically ill are associated with tumor necrosis factor- and interleukin-1-related gene polymorphisms. Crit Care Med 33:89-97
20. Fiedler VB, Loof I, Sander E, Voehringer V, Galanos C, Fournel MA (1992) Monoclonal antibody to tumor necrosis factor - alpha prevents lethal endotoxin sepsis in adult rhesus monkeys. J Lab Clin Med 120:574-588
21. Steinhauser ML, Hogaboam CM, Lukacs NW, Strieter RM, Kunkel SL (1999) Multiple roles for IL-12 in a model of acute septic peritonitis. J Immunol 162:5437-5443
22. Zisman DA, Kunkel SL, Strieter RM et al. (1997) Anti-interleukin-12 therapy protects mice in lethal endotoxemia but impairs bacterial clearance in murine Escherichia coli peritoneal sepsis. Shock 8:349-356
23. Heidecke CD, Weighardt H, Feith M et al. (2002) Neoadjuvant treatment of esophageal cancer: Immunosuppression following combined radiochemotherapy. Surgery 132:495-501
24. Arnalich F, Garcia-Palomero E, Lopez J et al. (2000) Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis. Infect Immun 68:1942-1945
25. Ikuta S, Ono S, Kinoshita M, Tsujimoto H, Yamauchi A, Mochizuki H (2003) Interleukin-18 concentration in the peritoneal fluid correlates with the severity of peritonitis. Am J Surg 185:550-555
26. Seidelin JB, Nielsen OH, Strom J (2002) Soluble L-selectin levels predict survival in sepsis. Intensive Care Med 28:1613-1618
27. Wunder C, Eichelbronner O, Roewer N (2004) Are IL-6, IL-10 and PCT plasma concentrations reliable for outcome prediction in severe sepsis? A comparison with APACHE III and SAPS II. Inflamm Res 53:158-163
28. Emmanuilidis K, Weighardt H, Matevossian E et al. (2002) Differential regulation of systemic IL-18 and IL-12 release during postoperative sepsis: high serum IL-18 as an early predictive indicator of lethal outcome. Shock 18:301-305
29. Arnalich F, Garcia-Palomero E, Lopez J et al. (2000) Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis. Infect Immun 68:1942-1945
30. Beer S, Weighardt H, Emmanuilidis K et al. (2002) Systemic neuropeptide levels as predictive indicators for lethal outcome in patients with postoperative sepsis. Crit Care Med 30:1794-1798
31. Resch B, Gusenleitner W, Muller WD (2003) Procalcitonin and interleukin-6 in the diagnosis of early-onset sepsis of the neonate. Acta Paediatr 92:243-245
32. Helfgott DC, Tatter SB, Santhanam U, Clarick RH, Bhardwaj N, May LT, Sehgal PB (1989) Multiple forms of IFN-beta 2/IL-6 in serum and body fluids during acute bacterial infection. J Immunol 142:948-953
33. Waage A, Halstensen A, Espevik T (1987) Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1:355-357
34. Calandra T, Gerain J, Heumann D, Baumgartner JD, Glauser MP (1991) High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study Group. Am J Med 91:23-29
35. Hack CE, De Groot ER, Felt-Bersma RJ et al. (1989) Increased plasma levels of interleukin-6 in sepsis. Blood 74:1704-1710
36. Panacek EA, Marshall JC, Albertson TE et al. (2004) Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab′)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit Care Med 32:2173-2182
37. Presterl E, Staudinger T, Pettermann M et al. (1997) Cytokine profile and correlation to the APACHE III and MPM II scores in patients with sepsis. Am J Respir Crit Care Med 156:825-832
38. Casey LC, Balk RA, Bone RC (1993) Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 119:771-778
39. Munoz C, Misset B, Fitting C, Bleriot JP, Carlet J, Cavaillon JM (1991) Dissociation between plasma and monocyte-associated cytokines during sepsis. Eur J Immunol 21:2177-2184
40. Wortel CH, der Mohlen MA, van Deventer SJ et al. (1992) Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels. J Infect Dis 166:1367-1374
41. Spittler A, Razenberger M, Kupper H et al. (2000) Relationship between interleukin-6 plasma concentration in patients with sepsis, monocyte phenotype, monocyte phagocytic properties, and cytokine production. Clin Infect Dis 31:1338-1342
42. Oberhoffer M, Vogelsang H, Russwurm S, Hartung T, Reinhart K (1999) Outcome prediction by traditional and new markers of inflammation in patients with sepsis. Clin Chem Lab Med 37:363-368
43. Damas P, Ledoux D, Nys M, Vrindts Y, De Groote D, Franchimont P, Lamy M (1992) Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 215:356-362
44. Struzyna J, Pojda Z, Braun B, Chomicka M, Sobiczewska E, Wrembel J (1995) Serum cytokine levels (IL-4, IL-6, IL-8, G-CSF, GM-CSF) in burned patients. Burns 21:437-440
45. Yamada Y, Endo S, Inada K (1996) Plasma cytokine levels in patients with severe burn injury - with reference to the relationship between infection and prognosis. Burns 22:587-593
46. Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E (1993) Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 103:565-575
47. Martin C, Saux P, Mege JL, Perrin G, Papazian L, Gouin F (1994) Prognostic values of serum cytokines in septic shock. Intensive Care Med 20:272-277
48. Zabel P, Wolter DT, Schonharting MM, Schade UF (1989) Oxpentifylline in endotoxaemia. Lancet 2:1474-1477
49. Cabioglu N, Bilgic S, Deniz G et al. (2002) Decreased cytokine expression in peripheral blood leukocytes of patients with severe sepsis. Arch Surg 137:1037-1043
50. Haupt W, Riese J, Mehler C, Weber K, Zowe M, Hohenberger W (1998) Monocyte function before and after surgical trauma. Dig Surg 15:102-104
51. Maruna P, Gurlich R, Frasko R, Chachkhiani I, Marunova M, Owen K, Peskova M (2002) Cytokines and soluble cytokine receptors in the perioperative period. Sb Lek 103:273-282
52. Menger MD, Vollmar B (2004) Surgical trauma: hyperinflammation versus immunosuppression? Langenbecks Arch Surg 389:475-484
53. Sendt W, Amberg R, Schoffel U, Hassan A, von Specht B. U, Farthmann EH (1999) Local inflammatory peritoneal response to operative trauma: studies on cell activity, cytokine expression, and adhesion molecules. Eur J Surg 165:1024-1030
54. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341:515-518
55. de W I, Jaccard C, Corradin SB et al. (1997) Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 25:607-613
56. Bertsch T, Richter A, Hofheinz H, Bohm C, Hartel M, Aufenanger J (1997) Procalcitonin. A new marker for acute phase reaction in acute pancreatitis. Langenbecks Arch Chir 382:367-372
57. Reith HB, Mittelkotter U, Debus ES, Kussner C, Thiede A (1998) Procalcitonin in early detection of postoperative complications. Dig Surg 15:260-265
58. McNelis J, Marini C, Kalimi R, Jurkiewicz A, Ritter G, Nathan I (2001) A comparison of predictive outcomes of APACHE II and SAPS II in a surgical intensive care unit. Am J Med Qual 16(5):161-165